The Second People's Hospital of Guangdong Province affiliated to Jinan University
Guangzhou, Guangdong, 510317, China
NCT Number: NCT07326761
The purpose of this study is to explore a potential exposure risk in the neonatal intensive care unit, namely, the iatrogenic microplastic exposure that critically ill newborns may face when receiving life-saving parenteral nutrition (intravenous nutrition delivered through a plastic infusion system). Therefore, the investigators designed a prospective study. By comparing three groups of newborns-those requiring long-term intravenous nutrition, short-term intravenous nutrition, and no intravenous nutrition-and collecting blood samples with strictly contamination-proof non-plastic instruments, the investigators used high-precision Raman spectroscopy for detection. For the first time, they attempted to systematically and quantitatively analyze the microplastic load in neonatal blood and its relationship with the duration of intravenous nutrition. The aim of this study is to provide novel scientific evidence for evaluating microplastic exposure in the neonatal medical environment, with the ultimate goal of establishing a basis for developing safer clinical practices and medical material standards in the future, thereby better protecting the long-term health of vulnerable newborns.
Looking for future studies?
Notify Me1 hour–2 month
All sexes
Interventional
Not applicable
Guangzhou, Guangdong, 510317, China
BACKGROUND: As a new environmental pollutant, microplastics has been found in many tissues of human body. Newborns, especially those who need intensive care and parenteral nutrition, may face a unique and persistent risk of microplastics exposure through plastic medical equipment, but their internal load is not clear.
Objective: The purpose of this study is to systematically evaluate the microplastics exposure of newborns in neonatal intensive care unit (NICU) during hospitalization through a prospective observation cohort, focusing on the potential relationship between the duration of parenteral nutrition and microplastics load.
Methods: Twelve newborns were recruited in 2025, and were divided into long-term exposure group, short-term exposure group and unexposed control group according to the support time of parenteral nutrition. In this study, blood samples of newborns were collected under strict pollution control, and microplastics in the samples was qualitatively and quantitatively analyzed by confocal micro-Raman spectroscopy.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
These infants received neither intravenous nutritional support nor planned fluid therapy, serving as baseline microplastic levels in the absence of iatrogenic exposure.
Time frame: parenteral nutrition support for over 14 days,parenteral nutrition support for 3-7 days,The first day after birth
The number of microplastics granules in newborn blood was detected.
Time frame: Day 1
questionnaire
Time frame: Day 1
questionnaire
Time frame: Day 1
questionnaire
Time frame: Day 1
questionnaire
Time frame: Day 1
questionnaire
Time frame: Day 1
questionnaire
Time frame: Day 1
physiological parameter
Time frame: Day 1
physiological parameter
Time frame: Day 1
physiological parameter
Time frame: Day 1
physiological parameter
Huiyi Li
Other
Acronym: Microplastics
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07562958
Fertility, Genital Diseases
View Trial DetailsNCT07620106
Hyperphagia, Malnourished Patients Requiring Artificial Nutritional Support
Bari, BA, Italy
View Trial DetailsNCT07604857
Digestive System Diseases, Digestive System Neoplasms
Seoul, South Korea
View Trial DetailsNCT06556277
Body Weight, Glucocorticoids
Basel, Canton of Basel-City, Switzerland
View Trial Details